Recombinant Human Relaxin in the Treatment of Diffuse Scleroderma

Systemic scleroderma

Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease Klotho and Mineral Bone Density in Systemic Sclerosis Longitudinal Spatial Frequency Domain Imaging Study Clinical Study of Divozilimab in Patients With Systemic Scleroderma Sleep Quality, Stress, Depression, Blood Pressure Responses to Diaphragmatic Respiratory Exercise in Systemic Sclerosis An Open-label Extension Trial of HZNP-HZN-825-301 in Adult Participants With Diffuse Cutaneous Systemic Sclerosis (Diffuse Cutaneous SSc) Phenotyping of Chronic Pain in Diffused Systemic Scleroderma A Study in People With Systemic Sclerosis to Test Whether BI 685509 Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms Quantification and Characterization of Circulating Epithelial and Endothelial Cells in Gougerot-Sjögren Syndrome, Compared to Systemic Sclerosis Personalized Home Respiratory Rehabilitation Program for Subjects With Systemic Sclerosis With Early Lung Disease Prospective Cohort of Patients With Systemic Sclerosis at Brest University Hospital With Biobanking. Nitric Oxide Lung Diffusing Capacity in Systemic Sclerosis Evaluation of HRCT Patterns in Systemic Sclerosis-associated Interstitial Lung Disease Stem Cell Factor, a Potential Biological Marker of Skin Involvement in Systemic Sclerosis? A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of RO7303509 in Participants With Systemic Sclerosis The Effect of Cognitive Exercise Therapy Approach in Individuals With Systemic Sclerosis Effectiveness of Cannabinoids on Appetite in Scleroderma Novel Splinting Technique Using 3D Models Interstitial Lung Disease Trajectories in Patients With Systemic Sclerosis Efficacy and Safety of Riociguat in Incipient Pulmonary Vascular Disease as an Indicator for Early PAH Structural and Functional Impairment of Multiple Organs in Patients With Systemic Sclerosis: A MR Imaging Study RIC alloBMT With Post-transplant Cyclophosphamide for Refractory Systemic Sclerosis A Study Evaluating the Efficacy and Safety of Baricitinib in Systemic Sclerosis Phase 2 Safety and Efficacy Study of PRA023 in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) Analysis of Dermal Fibroblasts and Immune Cells During Systemic Sclerosis COvid-19 Vaccine Booster in Immunocompromised Rheumatic Diseases Exercise in People With Systemic Sclerosis An Open-label, Phase 2 Study to Assess the Efficacy and Safety of Nemolizumab in Subjects With Systemic Sclerosis Antioxidant Profile in Patients With Systemic Sclerosis and Periodontitis Small Bowel Motility in Patients With Systemic Sclerosis Rheopheresis for Raynaud’s and Digital Ulcers in Systemic Sclerosis Treatment of Systemic Sclerosis With Autologous Regulatory Т-cells Phase 3 Study of MT-0551 in Patients With Systemic Sclerosis Efficacy and Safety of JAK Inhibitors in Systemic Sclerosis-associated Interstitial Lung Disease Efficacy of a Personalized Rehabilitation Program of Facial Involvement in Systemic Sclerosis Scleroderma: Functional Disability Between the Dominant and Contralateral Hand. Effectiveness of Bosentan Therapy in Patients With Systemic scleRosis and Progressive Digital ulcEr Disease. Open Label Extension Study of Brentuximab Vedotin in Early dcSSc PET Imaging of Systemic Sclerosis Using FDG and 68Ga-DOTA-Siglec-9 9 What is the Optimal Follow-up for Patients With Systemic Sclerosis? Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk A Safety and Efficacy Study of FCR001 in Adults With Rapidly Progressive Diffuse Cutaneous Systemic Sclerosis Upper Extremity Home Exercises in Patients With Scleroderma The Effects of Telerehabilitation Based Exercise Program in Patients With Systemic Sclerosis Rehabilitation Program in Patients With Scleroderma Autologous Stem Cell Transplant (ASCT) for Autoimmune Diseases Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell IV Infusion for Systemic Sclerosis ILD-SARDs Registry and Biorepository COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders Systemic Sclerosis and Innate T Cells Implementation of a Biological Sample Collection in Systemic Sclerosis Patients Extracorporeal Photopheresis in Early Diffuse Cutaneous Systemic Sclerosis Calcinosis Reduction by Pyrophosphate in SSC Impact of Transcutaneous Auricular Vagus Nerve Stimulation on Digestive Symptoms in Systemic Sclerosis Systemic Sclerosis Mycophenolate in Limited Cutaneous Systemic Sclerosis (MINIMISE-Pilot) Patient Reported Outcomes With UVA-1 Therapy for Treatment of Sclerosing Skin Diseases Search for Diagnostic and Prognostic Biomarkers in Systemic Sclerosis and Inflammatory Myopathies Systemic Sclerosis’ Relatives Reflex Apollo Device for Fatigue in Systemic Sclerosis A Study to Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients Effect of Ozone Therapy for the Treatment of Digital Ulcer in Patients With SSc Immunomodulating Effects of Supplementation With 25-OH Vitamin D Trichoscopy and Systemic Scleroderma Safety and Efficacy of Itacitinib in Adults With Systemic Sclerosis Study of the Intestinal Microbiota of Patients With Systemic Sclerosis A Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients With Diffuse Cutaneous Systemic Sclerosis Autologous Fat Grafting in the Treatment of Critical Limb Ischaemia A Study to Investigate Safety of GS-248 and Efficacy on Raynauds’ Phenomenon in Systemic Sclerosis Clinical Relevance of Thoracic Echography for the Early Diagnosis of Interstitial Lung Disease in Systemic Scleroderma – Pilot Study Effects of a Supervised Exercise Program and a Home Exercise Program in Patients With Systemic Sclerosis A Study of Guselkumab in Participants With Systemic Sclerosis Telerehabilitation Approach on Individuals With Hand-Affected Scleroderma Efficacy and Safety of Belumosudil in Subjects With Diffuse Cutaneous Systemic Sclerosis Effects of FT011 in Systemic Sclerosis Functional Exercise Tests in Patients With Systemic Sclerosis Evaluating Gut Imaging and Stool Biomarkers in Patients With Scleroderma-associated Gastrointestinal Disease Effect of the Use of Specific Oral Hygiene Devices on Gingival Health Among Patients With Systemic Sclerosis Effectiveness of Telerehabilitation on Scleroderma Optical Coherence Tomography Imaging in Systemic Sclerosis Iguratimod in Systemic Sclerosis Effectiveness of a Home-based, Self-administered Exercise Program for Hands in Patients With Systemic Sclerosis A Study With TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc) Utility of Breath-holding Test in Systemic Sclerosis Upfront Autologous HSCT Versus Immunosuppression in Early Diffuse Cutaneous Systemic Sclerosis Study to Evaluate Efficacy, Safety, and Tolerability of MT‑7117 in Subjects With Diffuse Cutaneous Systemic Sclerosis Frequency of Fibromyalgia Syndrome in Patients With Systemic Sclerosis Deployment o the Multidisciplinary Prospective Cohort Imminent Cold Challenge With C21 in RP Online Fatigue Intervention Program for People With Scleroderma Evaluation of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together Program The Effect of a Home-based Orofacial Exercise Program on Oral Aperture of Systemic Sclerosis Patients Assessment of Nutritional Status in Systemic Sclerosis Total Body Irradiation Using Intensity Modulated Radiation Therapy and Cyclophosphamide Prior to Stem Cell Transplant for the Treatment of Severe Systemic Sclerosis Evaluate Safety and Efficacy of Anaerobic Cultivated Human Intestinal Microbiome Transplantation in Systemic Sclerosis (ReSScue) Transplantation in Systemic Sclerosis Safety Of Fat Micrografts With Adipose-Derived Stromal Vascular Fraction In Hands Of Patients With Systemic Sclerosis Pilot Study of Description of Cicatrisation Rates of Digital Ulcers in Systemic Scleroderma Plasmacytoid Dendritic Cells and Toll Like Receptor 8 in Systemic Sclerosis A Study of KHK4827 in Patients With Systemic Sclerosis Subcutaneous Injections of Autologous ASC to Heal Digital Ulcers in Patients With Scleroderma. Is a History of Pre-eclampsia a Risk Factor for Vascular Phenotype in Women With Systemic Sclerosis? Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud Nivolumab in Treating Patients With Autoimmune Disorders or Advanced, Metastatic, or Unresectable Cancer CLUE Study: Connective Tissue Disease Leg Ulcer Etiology Study Auto-immunity and Pulmonary Arterial Hypertension Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome The CARRA Registry Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders Meir Medical Center Rheumatologic Biobank Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases New Orleans Pulmonary Hypertension Biobank Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease Objective Measurement Methods for Autoimmune Disease and Dry Eye Syndrome Early Therapy of Pulmonary Arterial Hypertension Cell Surface Marker Expression in Autoimmune Diseases Analysis of the Distribution of Regulatory B Cells in Blood of Multiple Sclerosis Patients Pulmonary Hypertension Screening for Rheumatology Patients (SOPHIE) Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary Fibrosis Volatile Organic Compounds (VOCs) as a Biomarker in Immune-mediated Pulmonary Arterial Hypertension (PAH) Idiopathic Pulmonary Fibrosis–Pathogenesis and Staging – SCOR in Occupational and Immunological Lung Diseases Study of Silicone-Associated Connective Tissue Diseases A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of GSK2330811 in Healthy Subjects Nonmyeloablative Allo Stem Cell Transplant for Severe Autoimmune Diseases Hemodynamic Changes in Connective Tissue Disease Long Term Effect of Buspirone on Esophageal Function and Esophageal Symptoms in Patients With Systematic Sclerosis (SSc) The Small Intestine Bacterial Overgrowth Study Pilot Treatment of Digital Ulcers in Korean Patients With Systemic Sclerosis: a Prospective Cohort Study Treprostinil Iontophoresis : a Pharmacodynamic and Pharmacokinetic Study A Study of the Efficacy and Safety of Rituximab in Participants With Systemic Sclerosis Suction Based Characterization of Healthy and Diseased Skin Connective Tissue Diseases and Lung Manifestations Development and Prevention of Severe Heart Disease in Systemic Sclerosis Bosentan Treatment of Digital Ulcers Related to Systemic Sclerosis Development and Prevention of Pulmonary Hypertension in Systemic Sclerosis The Effect of High Dose Methylprednisolone on Nailfold in Early Systemic Sclerosis ( SSc ) BIOLOGICAL EXPLORATION OF THE VASCULAR FRACTION FROM THE ADIPOSE TISSUE OF PATIENTS WITH SCLERODERMIA Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients Muscular Respiratory Involvement and Systemic Sclerosis CSL Behring Sclero XIII Cardiac Repercussion of Systemic Sclerodermias Itch and Clinacal Caracteristics in Systemic Sclerosis Intraoperative ICG for Systemic Sclerosis Prevention and Treatment of Digital Ulcers in Systemic Sclerosis Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud’s Phenomenon Secondary to Systemic Sclerosis Impact of Education and Training of Modified Rodnan Skin Scoring on the Reliability of Test A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren’s Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis Identifying Unique Pathogenic Macrophages in Systemic Sclerosis-ILD Divalproex Sodium in the Treatment of the Cutaneous Manifestations of Scleroderma Soluble VE-cadherin and VE-cadherin Antibody in Sclerodermic Sclerosis SCLERoderma et Adipose-DErived Stroma Cells Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis Cyclophosphamide Systemic Sclerosis Associated Interstitial Lung Disease The Role of Gastroesophageal Reflux in Scleroderma Pulmonary Fibrosis Clinical Trial of Probiotics in Systemic Sclerosis Associated Gastrointestinal Disease Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) Digital Ulceration Prevalence and Predictors of Proton Pump Inhibitor Partial Response in Gastroesophageal Reflux Disease in Systemic Sclerosis 7.0 Tesla Resonance Magnetic Imaging of the Hand in Systemic Sclerosis Effectiveness of Saccharomyces Boulardii for Gastrointestinal Bacterial-overgrowth in Systemic Sclerosis A Study to Test Whether Nintedanib Influences the Components of Birth-control Pills in Women With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD) Effect of Different Iloprost Doses on Symptoms in Systemic Sclerosis Sacroiliitis in Systemic Sclerosis Allogeneic Mesenchymal Stem Cells Transplantation for Systemic Sclerosis (SSc) Vasculopathy, Inflammation and Systemic Sclerosis A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis SPIN Self-Management Full-Scale Trial (SPIN-SELF) Non-Invasive Diagnostic and Functional Evaluation of Cardiac Involvement in Patients With Systemic Sclerosis Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension microRNAs in Systemic Scleroderma Study to Compare the Efficacy of Mycophenolate Mofetil in Systemic Sclerosis Related Early Interstitial Lung Disease The Benefit of Bermekimab in Patients With Systemic Sclerosis Psychological Treatments for Scleroderma SPIN Self-Management Feasibility Trial Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Patients With Systemic Sclerosis With Interstitial Lung Disease The Effects of Exercise in Patients With Systemic Sclerosis Placebo Controlled Trial of Bosentan in Scleroderma Patients Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (STAR) Light Treatment for Scleroderma Finger Ulcers Reduced Intensity Transplant in Medically Refractory Systemic Lupus Erythematosus (SLE) and Systemic Sclerosis (SSc) IL1-TRAP, Rilonacept, in Systemic Sclerosis Role of Macrophage Migratory Inhibitory Factor in Systemic Sclerosis A Comparison Between Two Educational Methods in the Rehabilitation of the Microstomia in Systemic Sclerosis Scleroderma Lung Study III – Combining Pirfenidone With Mycophenolate A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc) Pulmonary Arterial Hypertension in Systemic Sclerosis Treatment and Prevention of Progression of Interstitial Lung Disease in Systemic Sclerosis Effect of Rosuvastatin on Systemic Sclerosis-related Pulmonary Hypertension Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan SCOT Scleroderma Treatment Alternative Registry (STAR Registry) Obstructive Sleep Apnea in Scleroderma and Pulmonary Involvement Early Treatment of Borderline Pulmonary Arterial Hypertension Associated With Systemic Sclerosis (SSc-APAH) Platelet Gel in Systemic Sclerosis A Pilot Study to Evaluate the Safety and Efficacy of Oral Treprostinil in the Treatment of Calcinosis in Patients With Systemic Sclerosis Effectiveness of UVA1-irradiation in the Treatment of Early Skin Fibrosis in Patients Suffering From Systemic Sclerosis Rapamycin vs Methotrexate in Diffuse SSc Pragmatic Clinical Trials in Scleroderma Open-Label Study of Oral Treprostinil in Digital Ulcers Scleroderma Lung Disease Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With Scleroderma Bosentan in Systemic Sclerosis The Effect of Physical Therapy on Raynaud`s Phenomenon Secondary to Systemic Sclerosis Small Bowel Motor Impairment in Scleroderma: Results of a Prospective 5-year Manometric Follow-up Effect of Sildenafil on the Microcirculatory Blood Flow and Endothelial Progenitor Cells in Systemic Sclerosis Injection of Autologous Adipose-derived Stromal Vascular Fraction in the Finger of Systemic Sclerosis Patients Scleroderma Treatment With Autologous Transplant (STAT) Study A Study to Evaluate the Efficacy of an Oral Medication in the Treatment and Prevention of Digital Ulcers in Patients With Systemic Sclerosis (Scleroderma). Health-related Quality of Life in Korean Patients With Rheumatic Diseases Effectiveness and Safety of SAR156597 in Treating Diffuse Systemic Sclerosis Evaluation of the Serum Soluble Fractalkine as a Biomarker of Pulmonary Fibrosis in Systemic Sclerosis Phase II Study of Recombinant Relaxin for Progressive Systemic Sclerosis Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients With Diffuse Systemic Sclerosis Mesenchymal Stromal Cells as Treatment for Digital Ulcers in Systemic Sclerosis Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Patients With Scleroderma Scleroderma Patient-centered Intervention Network (SPIN) Hand Program Longitudinal Characterization of Microbial Signature in Systemic Sclerosis Patients Rehabilitation for Arm Coordination and Hand Movement in Systemic Sclerosis Subcutaneous Injection of Autologous Adipose Tissue-derived Stromal Vascular Fraction Into the Fingers of Patients With Systemic Sclerosis An Open-Label Study to Evaluate Biomarkers and Safety in Systemic Sclerosis Patients Treated With ABR-215757 (Paquinimod) Investigation of Coronary and Pulmonary Circulatory Parameters in Systemic Sclerosis Evaluating Lung Doppler Signals in Patients With Systemic Sclerosis (SSc) Evaluating Pulmonary Arterial Hypertension in Patients With Systemic Sclerosis Evaluation of Pulmonary Doppler Signals in Patients With Systemic Sclerosis(SSc) Low-Dose Oral Imatinib for Scleroderma Pulmonary Involvement FOLLOW HEART TRANSPLANT FOR ACHIEVING THE HEART PRIMITIVE RELATED SCLERODERMA SYSTEMIC Gastroesophageal Reflux Treatment in Scleroderma IgG-4 Levels in Systemic Sclerosis Safety and Value of Self Bone Marrow Transplants Following Chemotherapy in Scleroderma Patients A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis Cardiac Safe Transplants for Systemic Sclerosis The Clinical And Subclinical Effects on Arterial Stiffness of Bosentan in Patients With Systemic Sclerosis Scleroderma: Cyclophosphamide or Transplantation (SCOT) EFFECTS OF THE MICRO REINJECTION OF AUTOLOGOUS ADIPOSE TISSUE IN THE FACE OF PATIENTS WITH SYSTEMIC SCLEROSIS Trial of Topical C-82 in Systemic Sclerosis – A Phase I/II Biomarker and Safety Trial RElevance of UltraSonography for Assessing Salivary Gland Involvement in Systemic Sclerosis (SSc) A Pilot-Study of Sirolimus for the Treatment of Systemic Sclerosis Small Intestinal Mucosal Abnormalities in Systemic Sclerosis Using Capsule Endoscopy Mycophenolate Mofetil Pharmacokinetics in Systemic Sclerosis Laser Speckle Contrast Imaging for Cutaneous Microvascular Dysfunction Detection in Systemic Sclerosis. Scleroderma Patient-centered Intervention Network (SPIN) Hand Program Feasibility Study Treatment of Refractory Sever Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells Detecting Pulmonary Arterial Hypertension (PAH) in Patients With Systemic Sclerosis (SSc) by Ultrasound Dimethyl Fumarate (DMF) in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension Individualized Home-based Exercise Program for Patient With Systemic Sclerosis. Effects of Intensive Aerobic and Muscle Endurance Exercise in Patients With Systemic Sclerosis – a Pilot Study Immunoadsorption in Patients With Severe Systemic Sclerosis MPA AUC Monitoring in Patients Receiving MMF for Diffuse Cutaneous or Pulmonary Involvement in Systemic Sclerosis Oral Health and People With Systemic Sclerosis Treprostinil Iontophoresis in Systemic Sclerosis Digital UlcErations. A Proof of Concept Study Vocal Intervention in Systemic Sclerosis Genetic Study of the FBN1 Gene and Fibrillin-1 Abnormalities in Choctaw Native Americans and Other Patients With Systemic Sclerosis Swallowing Difficulties With Medication Intake and Coping Strategies in Patients With Systemic Sclerosis Topical Rosemary Oil Application in Systemic Sclerosis Pirfenidone as Treatment of Skin Fibrosis in Systemic Sclerosis Improvement of Hand Dysfunction by Arthritis in Systemic Sclerosis Autologous Adipose Tissue in the Treatment of Systemic Sclerosis Digital Ulcers Efficacy and Safety of Riociguat in Patients With Systemic Sclerosis Stress Echocardiography in the Detection of Pulmonary Arterial Hypertension in Systemic Sclerosis Patients Imatinib in Systemic Sclerosis ADMSCs for the Treatment of Systemic Sclerosis Efficacy and Safety of Imatinib in Scleroderma Endothelial Microparticles in Systemic Sclerosis Pulmonary Hypertension Microparticles’s Role in the Pathophysiology of Systemic Lupus Erythematosus and Systemic Sclerosis Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis Neutrophil Extracellular Traps in Systemic Sclerosis Cyclophosphamide and rATG With Hematopoietic Stem Cell Support in Systemic Scleroderma Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial Efficacy and Safety of IgPro10 in Adults With Systemic Sclerosis (SSc) A Study Using The Experimental Drug Called Imatinib (Gleevec) in Subjects With Systemic Sclerosis Role of Circulating Cytotoxic Lymphocytes in Endothelial Cell Injury in Systemic Sclerosis Role of Eosinophil in Fibrogenesis of Systemic Sclerosis Gut Microbiota Transplantation in Systemic Sclerosis Assessment of the Subcutaneous Reinjection of Human Autologous Adipose-derived Stromal Vascular Fraction (Celution® System) in the Hands of Patients Suffering From Systemic Sclerosis Recombinant Human Relaxin in the Treatment of Diffuse Scleroderma The Impact of Illness Perceptions on Health Related Outcomes in Patients With Lupus and Systemic Sclerosis Brentuximab Vedotin for Systemic Sclerosis A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma) Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine Oral Manifestations of Systemic Sclerosis Duke Scleroderma Clinic Patient Registry Trial of IC351 in Female Scleroderma Patients With Raynaud’s and Sexual Dysfunction Rituximab in Systemic Sclerosis Clinical and Paraclinical Characteristics of the Systemic Scleroderma Cohort According to the Criteria ACR 2013 and the History of Professional Exposure or of Agricultural Environment Pulmonary Involvement in Scleroderma: A Clinical Study of the Safety and Efficacy of Mycophenolate Mofetil in Scleroderma Patients With Lung Involvement Angiogenic/Angiostatic Mediators in Patients With Systemic Sclerosis Echo Systemic Sclerosis Proof of Biological Activity of SAR100842 in Systemic Sclerosis Low-Dose Conditioning Followed by Donor Stem Cell Transplant in Treating Patients With Severe Systemic Sclerosis Stem Cell Transplant to Treat Patients With Systemic Sclerosis Pharmacokinetics of Oral Treprostinil in Patients With Systemic Sclerosis Systemic Sclerosis Clinical and Biomarker Study Skin Biopsy Specimens as Biomarkers of Systemic Sclerosis and Response to Mycophenolate Mofetil Description of the Functional Evolution of Diffuse Infiltrating Pneumonia Associated With Systemic Scleroderma. The Scleroderma Patient-centered Intervention Network (SPIN) Support Group Leader Education Program Feasibility Trial Lysyl Oxidase, Semaphorin 7a and Semaphorin 3a in Patients With Systemic Sclerosis Profibrosing Role of B Lymphocytes in Patients With Systemic Sclerosis. Safety and Tolerability of Pirfenidone in Participants With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS) Sildenafil Effect on Digital Ulcer Healing in sClerodErma SEDUCE STUDY Efficacy and Safety Study of GB-0998 for Treatment of Systemic Sclerosis Analysis of Cytokine Expression Pattern in Systemic Sclerosis Effects of a Personalized Standardized Rehabilitation Program in Systemic Sclerosis AIMSPRO in Established Diffuse Cutaneous Systemic Sclerosis Safety and Pharmacokinetics of IgPro20 and IgPro10 in Adults With Systemic Sclerosis (SSc) Safety, Tolerability, and Pharmacokinetics of CAT-192 (Human Anti-TGF-Beta1 Monoclonal Antibody) in Patients With Early Stage Diffuse Systemic Sclerosis The Effect of Physiotherapy Program in Scleroderma Patients Proof-of-concept Trial of IVA337 in Diffuse Cutaneous Systemic Sclerosis Prednisolone in Early Diffuse Systemic Sclerosis Mycophenolate Mofetil in Systemic Sclerosis KD025 in Subjects With Diffuse Cutaneous Systemic Sclerosis Evaluation of Effectiveness of Acetylsalicylic Acid on Markers of Vascular Dysfunction in Scleroderma Patients Brentuximab Vedotin in Early Diffuse Cutaneous Systemic Sclerosis Effect of Bosentan on Skin Fibrosis in Patients With Systemic Sclerosis Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients Evaluation of Tofacitinib in Early Diffuse Cutaneous Systemic Sclerosis (dcSSc) Evaluation of Aesthetic Impact in Patients With Systemic Sclerosis Thalidomide for Decreasing Collagen Biosynthesis in People With Progressive Systemic Sclerosis Seoul National University Hospital Systemic Sclerosis Cohort Conception of an ICF Core Set for Systemic Sclerosis Effects of Probiotics on Gastrointestinal Symptoms and on the Immune System in Patients With Systemic Sclerosis Allogeneic Hematopoietic Cell Transplantation for Severe Systemic Sclerosis Fresolimumab In Systemic Sclerosis Serial Night Time Position Splint on Systemic Sclerosis Systemic Sclerosis and Jak Inhibitors : Emphasis on Macrophages Evaluation of Calcinosis in Systemic Sclerosis Professional and Personal Toxic Exposure in Systemic Sclerosis : Type, Intensity and Probability of Exposition Imatinib Mesylate (Gleevec) in the Treatment of Systemic Sclerosis Scleroderma Registry Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis A Systematic Review of Factors Associated With Pulmonary Arterial Hypertension in Systemic Sclerosis Trial on Outpatients With Systemic Sclerosis Treated With Well-Being Therapy or With a Control Therapy Safety, Tolerability, Efficacy, and Pharmacokinetics of JBT-101 in Systemic Sclerosis Stimulatory Autoantibodies to the Platelet-Derived Growth Factor Receptor (PDGFR) in Patients With Systemic Sclerosis Lower Urinary Tract Symptoms in Systemic Sclerosis Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis Cohort of Patients With Systemic Sclerosis Within the Framework of the RESO Reference Centre Neuropsychiatric Scleroderma Study: Systematic Evaluation of Neuropsychiatric Involvement in Systemic Sclerosis Evaluation of Safety, Tolerability and Preliminary Efficacy of EHP-101 in Diffuse Cutaneous Systemic Sclerosis The SPIN – Scleroderma Support Group Leader EDucation Program Trial (SPIN-SSLED) Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis Study of Ambrisentan With Antifibrotic Agent Combination Therapy in Diffuse Systemic Sclerosis Mouth Handicap in Systemic Sclerosis Questionnaire (MHISS) in Turkish IVIG Treatment in Systemic Sclerosis Nilotinib in the Treatment of Systemic Sclerosis